Company Profile Boards & Staffs Memberships & Partners Academy of Journalism Careers Blog(EN)Contact Us

Our Journals Instruction for Authors Brieflands Policies Publish My Research Journal Management System Article Processing Charges Open Peer Review Publishing Services

Publish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue Accepted Manuscripts All Issues In Press Articles Search

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Crossref

1. Association of Mutations in the NS5A-PKRBD Region and IFNL4 Genotypes with Hepatitis C Interferon Responsiveness and its Functional and Structural Analysis

- Tayebeh Hashempour

- Behzad Dehghani

- Zahra Mousavi

- Tahereh Akbari

- Zahra Hasanshahi

- Javad Moayedi

- Maryam Yahaghi

- Mohammad Ali Davarpanah

2. IL28B polymorphism (rs12979860) associated with clearance of HCV infection in Poland: Systematic review of its prevalence in chronic hepatitis C patients and general population frequency

- Marcin P. Kaczor

- Marta Seczyńska

- Wojciech Szczeklik

- Marek Sanak

3. The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C

- Krzysztof Domagalski

- Małgorzata Pawłowska

- Dorota Kozielewicz

- Dorota Dybowska

- Andrzej Tretyn

- Waldemar Halota

- Chen-Hua Liu

4. Single nucleotide polymorphisms near IL28B gene and response to treatment of chronic hepatitis C in hemodialysis patients

- Pavlina Dzekova-Vidimliski

- Igor G. Nikolov

- Nadica Matevska-Geshkovska

- Sami Mena

- Lionel Rostaing

- Aleksandar Dimovski

- Aleksandar Sikole

5. Association of the Treatment Induced Clearance of Hepatitis C Virus Infection with the IL28B Gene Polymorphisms

- PD Vidimliski

- IG Nikolov

- NM Geshkovska

- Y Boyanova

- N Nikolova

6. Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients

- Abdolvahab Alborzi

- Tayebeh Hashempour

- Javad Moayedi

- Zahra Musavi

- Gholamreza Pouladfar

- Shahin Merat

7. IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C

- Parvaneh Sedighimehr

- Shiva Irani

- Fatemeh Sakhaee

- Farzam Vaziri

- Mohammadreza Aghasadeghi

- Seyed Mehdi Sadat

- Fatemeh Rahimi Jamnani

- Abolfazl Fateh

- Seyed Davar Siadat

8. Genetic screening to avoid adverse drug reactions from medication use and approach patients' better outcomes: A lesson learn from the report of the Queen Savang Vadhana Memorial Hospital

- Kessada Tunwongsa

- Malinee Chonnawakul

- Nopavut Geratikornsupuk

- Karunrat Tewthanom

9. Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients

- Arghavan Haj-sheykholeslami

10. Polymorphisms at IL28B gene as predictors of viral relapse in genotype 4 Egyptian hepatitis C patients

- Mona Abdelmonem Esmail

- Noha A. Hassuna

- Khalda Sayed Amr

- Eman Ramadan Ghazawy

- Mohamed Abdel‐Hamid

11. Are statins a viable option for the treatment of infections with the hepatitis C virus?

- Ben Verpaalen

- Johan Neyts

- Leen Delang

12. Pegylated interferon and ribavirin gone but not forgotten in the era of direct-acting antivirals

- Magdalena PLUTA

- Maria POKORSKA-ŚPIEWAK

- Małgorzata ANISZEWSKA

- Zbigniew LEWANDOWSKI

- Barbara KOWALIK-MIKOŁAJEWSKA

- Magdalena MARCZYŃSKA